Ertumaxomab

Embed this Topic
Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. As of September 2009, a Phase II clinical trial evaluating the treatment of breast cancer is recruiting participants. It works by linking T-lymphocytes and macrophages to the cancer cells.
Read article at Wikipedia

Facts from the Community

From the BioVenturist base

Technology involved:

top ↑

We can tell you that Ertumaxomab is a…

If you know more about Ertumaxomab, you can add more facts here »

Similar topics in Freebase

  • Motavizumab

    Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III...

  • Priliximab

    Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licencing. The patent belongs to the biotechnology company Centocor.

  • Atlizumab

    Atlizumab is a humanized monoclonal antibody which is used as an immunosuppressive drug.

  • Efungumab

    Efungumab (trade name Mycograb) is a human monoclonal antibody developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive Candida infection in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb,...

  • Libivirumab

    Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.

  • Lexitumumab

These people have edited this topic:

  • tristan Metaweb Staff
Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Ertumaxomab was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution